SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-008120
Filing Date
2022-03-01
Accepted
2022-03-01 17:30:05
Documents
5
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 sndx-s8.htm S-8 79252
2 EX-5.1 sndx-ex51_16.htm EX-5.1 7970
3 EX-23.1 sndx-ex231_18.htm EX-23.1 2737
4 EX-FILING FEES sndx-exfilingfees_17.htm EX-FILING FEES 31676
5 GRAPHIC ggu4axvtipol000001.jpg GRAPHIC 34199
  Complete submission text file 0001564590-22-008120.txt   169925
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263185 | Film No.: 22699927
SIC: 2834 Pharmaceutical Preparations